Furthermore, CXCL14 was found to be highly expressed in subtype 1 and studies suggested that this chemokine is responsible for better prognosis in prostate cancer which opens up a possibility for this chemokine to become an effective marker for bladder cancer. The gene discussed is CXCL14; the disease is prostate carcinoma.